GLP-1 weight-loss drugs are transforming healthcare, but what could that mean for investors
Medications like Liraglutide (Saxenda) and Dulaglutide (Trulicity) mimic GLP-1's effects, leading to reduced calorie intake and weight loss
The price difference between a legitimate dermatologist-led clinic and a beauty parlour quoting drip rates is the difference between a treatment and a gamble
While there is not yet enough evidence to recommend GLP-1 medications specifically for lymphedema prevention, the concept is generating significant discussion within the medical community
This week: tirzepatide vs semaglutide results from 20,000+ patients, new data on the start-and-stop journey, groundbreaking research on GLP-1s rewiring impulsive behaviour, and why your step count matters more than you think.Plus Father's Day waffle, World Cup chat, and the first ever fully integrated sponsor on the channel.This week's stories: Tirzepatide vs Semaglutide: Real-world data from 20,000+ patients The Start & Stop trend 58% restart within 2 years GLP-1s and impulsive behaviour: the brain rewiring study Physical activity drop & the muscle loss warning Check out all the update videos on YouTube: YouTube Weekly Videos *The episodes in this series are recorded as YouTube videos
